Trial intelligence / Profile preview

Articaine versus mepivacaine for lingual anesthesia after mandibular anterior infiltration

IRCT20170307032929N4Phase 2Completed

Sponsor
Islamic Azad University
Start
Feb 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label trial of articaine and mepivacaine in None (2 arms), sponsored by Islamic Azad University. Primary endpoint: Pain during lingual decollation. Started Feb 2021; status: completed.

02

Drugs

articainemepivacaine

Beyond the preview

Go deeper on IRCT20170307032929N4.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20170307032929N4.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call